Valuation: Danaher Corporation

Market Cap 165B 148B 136B 123B 234B 15,505B 239B 1,625B 648B 8,301B 621B 608B 26,144B P/E 2026 *
37.4x
P/E 2027 * 31.3x
Enterprise Value 186B 166B 153B 139B 263B 17,434B 269B 1,827B 728B 9,333B 698B 683B 29,396B EV / Sales 2026 *
7.08x
EV / Sales 2027 * 6.42x
Free-Float
70.57%
Yield 2026 *
0.62%
Yield 2027 * 0.67%
1 day+2.12%
1 week+3.14%
Current month+1.24%
1 month+6.97%
3 months+14.83%
6 months+37.37%
Current year+2.71%
1 week 222.96
Extreme 222.96
238.45
1 month 217.55
Extreme 217.55
238.46
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 76.27
Extreme 76.27
333.96
Manager TitleAgeSince
Chief Executive Officer - 01/10/2026
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap. Importance
10/30/26 A Free

Director

13 0.0000%
10/30/26 A Free

Director

193 0.0000%
10/30/26 A Free

Director

144 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+2.12%+3.14%+11.99%+20.25% 162B
+3.87%+5.71%+26.07%+62.43% 257B
+1.71%+5.42%-17.76%+69.07% 157B
+2.97%-0.68%-55.99%-14.41% 61.96B
+2.52%+12.28%+25.57%+61.96% 58.73B
-3.36%-0.55%-0.30%-10.70% 55.42B
+3.10%+4.76%+22.78%+67.23% 49.27B
+0.88%-0.20%+3.91%+83.91% 49.18B
+4.17%+6.04%+28.25%+88.36% 44.96B
+2.00%+5.63%+15.03%+23.01% 37.25B
Average +2.00%+4.03%+5.96%+45.11% 93B
Weighted average by Cap. +2.37%+4.40%+7.53%+47.81%

Financials

2026 *2027 *
Net sales 26.26B 23.44B 21.57B 19.58B 37.1B 2,462B 38.02B 258B 103B 1,318B 98.57B 96.46B 4,151B 28.28B 25.25B 23.23B 21.08B 39.96B 2,651B 40.95B 278B 111B 1,419B 106B 104B 4,470B
Net income 4.4B 3.92B 3.61B 3.28B 6.21B 412B 6.36B 43.2B 17.22B 221B 16.5B 16.15B 695B 5.22B 4.66B 4.28B 3.89B 7.37B 489B 7.55B 51.24B 20.42B 262B 19.57B 19.16B 824B
Net Debt 20.58B 18.37B 16.9B 15.34B 29.07B 1,929B 29.79B 202B 80.59B 1,033B 77.24B 75.59B 3,252B 16.09B 14.36B 13.21B 11.99B 22.72B 1,508B 23.29B 158B 62.99B 807B 60.37B 59.08B 2,542B
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
09/11/26 $235.12 +2.12% 3,630,558
06/11/26 $230.25 +1.73% 4,061,071
05/11/26 $226.34 -3.66% 5,138,041
04/11/26 $234.93 +2.09% 3,055,473
03/11/26 $230.11 +0.94% 2,688,094
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
235.12USD
Average target price
259.90USD
Spread / Average Target
+10.54%